Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bragar Eagel & Squire, P.C. Is Investigating DocGo, and Ramaco and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Roblox, ChargePoint, Expensify, and National Instruments and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LivePerson, EHang, Blue Ridge Bankshares, and Lovesac and Encourages Investors to Contact the Firm
-
Winnebago Industries Announces Pricing of $300 Million Offering of Convertible Senior Notes for Refinancing 2025 Maturities
-
Home Federal Bancorp, Inc. of Louisiana Declares Quarterly Cash Dividend
-
NowVertical Group Comments on Press Release Issued by Daren Trousdell
-
ROSEN, A RANKED AND LEADING FIRM, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – BRBS
-
Vishay Intertechnology Upgrades TSOP18xx, TSOP58xx, and TSSP5xx Series IR Receiver Modules With New In-House IC
-
Purpose Investments Inc. Announces January 2024 Distributions
-
Decentralized Filmmaking Platform Film.io Debuts During Sundance Film Festival
-
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
-
VCI Global Announces Closing of $2.75 Million Public Offering
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ChargePoint Holdings, Inc. Investors to Secure Counsel Before Important January 29 Deadline in Securities Class Action – CHPT
-
Targa Resources Corp. Announces Quarterly Dividend and Timing of Fourth Quarter 2023 Earnings Webcast
-
United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
-
United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DRVN
-
Adams Natural Resources Fund Declares Distribution
-
Adams Natural Resources Fund Announces 2023 Performance
-
Adams Diversified Equity Fund Declares Distribution
-
Adams Diversified Equity Fund Announces 2023 Performance
-
Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
-
UPDATE – Budding Entrepreneurs Invited to Utah Tech Week Elevator Pitch Competition
-
Brink’s Declares Quarterly Dividend
-
After Crossing 100,000 Active Users, Hypeloot.com Announces The Launch of Its Utility Token $HPLT
-
DefiQuant: Revolutionizing 2024’s Bitcoin Trading for Daily Passive Income
-
UnitedAg Welcomes Three New Members to Board of Directors
-
FSIS Public Health Alert 01182024 - PRODUCED WITHOUT BENEFIT OF INSPECTION
-
Hubbell to Announce Fourth Quarter 2023 Results on January 30, 2024
-
Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
-
Toll Brothers Opens Two Model Homes at The Ridge at Big Rock Community in Duvall, Washington
-
Nexus Industrial REIT Announces January and February Distributions
-
Interfield Global Software Inc. Enters Into Non-Binding Memorandum of Understanding With JRL Energy Inc.
-
Skyharbour Announces Additional Uranium Property Acquisitions in the Athabasca Basin, Saskatchewan, as well as Marketing Contracts
-
Clearfield Sets Fiscal First Quarter 2024 Earnings Call for Thursday, February 1, 2024
-
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
-
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
-
Peloton Interactive, Inc. Announces Second Quarter Fiscal 2024 Earnings Release Date, Conference Call, and Webcast
-
IsoEnergy Announces C$15 Million Bought Deal Private Placement
-
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depressi
-
Lincoln Electric Schedules Webcast for Fourth Quarter and Full Year 2023 Results
-
Arisz Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
-
Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024
-
Kane Biotech Announces Special Meeting of Shareholders
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Dollar General Corporation Investors to Secure Counsel Before Important January 26 Deadline in Securities Class Action – DG
-
GOGL – Changes to the Board composition
-
Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program
-
Carriage Services Declares Quarterly Cash Dividend
-
Carpenter Technology Declares Quarterly Cash Dividend
-
Bird Bolsters Capabilities, Capacity, and Recurring Revenue With Agreement to Acquire Leading Alberta Electrical Service Provider
